Literature DB >> 2848785

11C-labelling of Ro 15-1788 in two different positions, and also 11C-labelling of its main metabolite Ro 15-3890, for PET studies of benzodiazepine receptors.

C Halldin1, S Stone-Elander, J O Thorell, A Persson, G Sedvall.   

Abstract

The benzodiazepine receptor antagonist Ro 15-1788 has been labelled with 11C in two different positions [( methyl-11C]Ro 15-1788 (I) and [ethyl-11C]Ro 15-1788 (II]. Product I was prepared by N-alkylation of the desmethyl compound (Ro 15-5528) with [11C]methyl iodide and product II was prepared by esterification of the desethyl compound (Ro 15-3890) with [11C]ethyl iodide. Ro 15-3890, the main metabolic product of Ro 15-1788, was labelled by two synthetic routes. In route A, [methyl-11C]Ro 15-3890 (III) was prepared by N-alkylation of the corresponding desmethyl compound (Ro 15-6877) with [11C]methyl iodide. In route B, III was prepared by a subsequent hydrolysis of I. The radiochemical yields were on the order of 15-60% (EOB) with an overall synthesis time of 40-50 min. Compounds I, II and III were isolated by semi-preparative HPLC and the radiochemical purity was in all cases greater than 99%.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848785     DOI: 10.1016/0883-2889(88)90044-5

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum A        ISSN: 0883-2889


  12 in total

1.  [11C]Ro 15-4513, a ligand for visualization of benzodiazepine receptor binding. Preparation, autoradiography and positron emission tomography.

Authors:  C Halldin; L Farde; J E Litton; H Hall; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology.

Authors:  G Stöcklin
Journal:  Eur J Nucl Med       Date:  1992

3.  Three-dimensional visualization and quantification of the benzodiazepine receptor population within a living human brain using PET and MRI.

Authors:  S Pauli; G Sedvall
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

4.  Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ).

Authors:  Charles M Laymon; Rajesh Narendran; Neale S Mason; Jonathan P Carney; Brian J Lopresti; Chester A Mathis; James M Mountz; Donald Sashin; W Gordan Frankle
Journal:  Mol Imaging Biol       Date:  2012-02       Impact factor: 3.488

5.  Plasma pharmacokinetics and metabolism of the benzodiazepine antagonist [11C] Ro 15-1788 (flumazenil) in baboon and human during positron emission tomography studies.

Authors:  D Debruyne; P Abadie; L Barre; F Albessard; M Moulin; E Zarifian; J C Baron
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Apr-Jun       Impact factor: 2.441

6.  In vivo demonstration of altered benzodiazepine receptor density in patients with generalised epilepsy.

Authors:  I Savic; S Pauli; J O Thorell; G Blomqvist
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-07       Impact factor: 10.154

7.  Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects.

Authors:  W Gordon Frankle; Raymond Y Cho; Rajesh Narendran; N Scott Mason; Shivangi Vora; Maralee Litschge; Julie C Price; David A Lewis; Chester A Mathis
Journal:  Neuropsychopharmacology       Date:  2008-07-09       Impact factor: 7.853

8.  In-vivo imaging characteristics of two fluorinated flumazenil radiotracers in the rat.

Authors:  Stefanie Dedeurwaerdere; Marie-Claude Gregoire; Lucy Vivash; Peter Roselt; David Binns; Christopher Fookes; Ivan Greguric; Tien Pham; Christian Loc'h; Andrew Katsifis; Rodney J Hicks; Terence J O'Brien; Damian E Myers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-10       Impact factor: 9.236

9.  PET analysis of alcohol interaction with the brain disposition of [11C]flumazenil.

Authors:  S Pauli; S Liljequist; L Farde; C G Swahn; C Halldin; J E Litton; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci.

Authors:  I Savic; M Ingvar; S Stone-Elander
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.